CD40.PCA / EnnoDC - LARVOL DELTA

METTL3/YTHDF1-Driven SURF6 Promotes Prostate Cancer Stemness via CDK4. (PubMed, J Cell Mol Med) - "In vivo experiments confirmed that knockdown of SURF6 inhibits tumour growth and reduces stemness features in xenograft models. Overall, our study underscores the critical role of SURF6 in promoting PCa progression and highlights its potential as a therapeutic target, paving the way for future research focused on targeting SURF6 in clinical settings to improve treatment strategies for PCa."

Journal • Genito-urinary Cancer • Oncology • Prostate Cancer • Solid Tumor • CDK4 • METTL3 • NANOG • YTHDF1